DW Healthcare Partners Invests in Parnell Pharmaceuticals
February 1, 2021
DW Healthcare Partners completed an investment in Parnell Pharmaceuticals Holdings Ltd, a fully integrated animal-health pharmaceutical developer and sterile-injectable manufacturer, and took seats on the company's board. DWHP said the capital and board expansion will support Parnell's growth in the U.S. and expansion of its product portfolio and manufacturing capabilities in animal health.
- Buyers
- DW Healthcare Partners, White Oak Healthcare Finance
- Targets
- Parnell Pharmaceuticals Holdings Ltd (Parnell)
- Sellers
- Parnell shareholders, Public shareholders
- Industry
- Veterinary
- Location
- New South Wales, Australia
- Transaction Type
- Recapitalization
Explore More
Related Acquisitions
-
DW Healthcare Partners Invests in Vets Plus and Noble Pharma
January 10, 2022
Veterinary
DW Healthcare Partners completed a growth capital investment in Vets Plus, Inc. and Noble Pharma, LLC, backing the animal-health manufacturer to scale operations and expand pharmaceutical capabilities. As part of the transaction, Dave Nelson becomes President and CEO of Vets Plus while founder Raj Lall transitions from day-to-day management and remains on the board.
-
DW Healthcare Partners Invests in Bio Agri Mix
July 27, 2021
Veterinary
DW Healthcare Partners completed an investment in Bio Agri Mix LP, Canada’s largest manufacturer and distributor of medicated feed additives and water-soluble animal medications. As part of the transaction DWHP partners join Bio Agri Mix’s board and will support expansion of the company’s product portfolio and growth across the North American livestock market.
-
Partners Group Acquires Wedgewood Pharmacy from New Harbor Capital
December 9, 2020
Healthcare Services
Partners Group, a global private markets investment manager, has acquired a majority stake in Wedgewood Pharmacy from New Harbor Capital. Wedgewood is a leading U.S. compounding pharmacy for animal health that employs over 700 people across multiple states and serves tens of thousands of veterinarians and hundreds of thousands of pet owners; the deal closed April 1, 2021.
-
Dechra Pharmaceuticals Acquires Med-Pharmex from DW Healthcare Partners
August 30, 2022
Veterinary
Dechra Pharmaceuticals PLC has completed the acquisition of Med-Pharmex Holdings, Inc. from DW Healthcare Partners. The deal brings a US-based, fully integrated veterinary pharmaceutical manufacturer (Med-Pharmex) into Dechra's global animal-health platform to strengthen its manufacturing capabilities and North American footprint.
-
CarePartners Pharmacy Acquires National Drug Wholesale (NDW)
November 17, 2025
Pharmaceuticals
CarePartners Pharmacy, a national specialty infusion pharmacy based in Libertyville, Illinois, has acquired National Drug Wholesale (NDW), a Santa Clara, California–based pharmaceutical wholesaler and distributor. The deal expands CarePartners’ specialty distribution capabilities, strengthens its biosimilar supply chain and licensing footprint, and supports its payer- and manufacturer-focused cost-containment programs.
-
NMS Capital Recapitalizes Health & Wellness Partners
March 7, 2023
Healthcare Services
NMS Capital has completed a recapitalization investment in Health & Wellness Partners Group, LLC (HWP), partnering with HWP's management team. HWP, a medical communications provider based in Upper Saddle River, New Jersey, will use the investment to accelerate growth by expanding therapeutic expertise and service offerings; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.